Multicenter Phase II Study of Apatinib in Patients With Advanced Breast Cancer(CABC006)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Apatinib
Sponsor: Peking University Cancer Hospital & Institute
Collaborators: Hebei Medical University Fourth Hospital|Peking University First Hospital|Peking University Third Hospital|Shanxi Province Cancer Hospital